1. Home
  2. ELTX vs KLXE Comparison

ELTX vs KLXE Comparison

Compare ELTX & KLXE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELTX
  • KLXE
  • Stock Information
  • Founded
  • ELTX 2011
  • KLXE 2018
  • Country
  • ELTX United States
  • KLXE United States
  • Employees
  • ELTX N/A
  • KLXE N/A
  • Industry
  • ELTX Biotechnology: Pharmaceutical Preparations
  • KLXE Oilfield Services/Equipment
  • Sector
  • ELTX Health Care
  • KLXE Energy
  • Exchange
  • ELTX Nasdaq
  • KLXE Nasdaq
  • Market Cap
  • ELTX 49.7M
  • KLXE 90.4M
  • IPO Year
  • ELTX 2021
  • KLXE N/A
  • Fundamental
  • Price
  • ELTX $4.16
  • KLXE $4.49
  • Analyst Decision
  • ELTX Buy
  • KLXE Hold
  • Analyst Count
  • ELTX 2
  • KLXE 1
  • Target Price
  • ELTX $10.00
  • KLXE $4.50
  • AVG Volume (30 Days)
  • ELTX 16.1K
  • KLXE 92.5K
  • Earning Date
  • ELTX 11-07-2024
  • KLXE 11-04-2024
  • Dividend Yield
  • ELTX N/A
  • KLXE N/A
  • EPS Growth
  • ELTX N/A
  • KLXE N/A
  • EPS
  • ELTX N/A
  • KLXE N/A
  • Revenue
  • ELTX N/A
  • KLXE $769,700,000.00
  • Revenue This Year
  • ELTX N/A
  • KLXE N/A
  • Revenue Next Year
  • ELTX N/A
  • KLXE $3.17
  • P/E Ratio
  • ELTX N/A
  • KLXE N/A
  • Revenue Growth
  • ELTX N/A
  • KLXE N/A
  • 52 Week Low
  • ELTX $2.96
  • KLXE $4.18
  • 52 Week High
  • ELTX $11.45
  • KLXE $12.13
  • Technical
  • Relative Strength Index (RSI)
  • ELTX 40.82
  • KLXE 33.44
  • Support Level
  • ELTX $4.05
  • KLXE $4.31
  • Resistance Level
  • ELTX $4.89
  • KLXE $4.59
  • Average True Range (ATR)
  • ELTX 0.28
  • KLXE 0.31
  • MACD
  • ELTX -0.06
  • KLXE -0.05
  • Stochastic Oscillator
  • ELTX 27.37
  • KLXE 8.92

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking. Elicio is engineering lymph node-targeted AMPlifiers, immunomodulators, adjuvants, and vaccines for an array of aggressive cancers. It has developed its cancer vaccine product candidates to target biologically validated tumor mutation drivers using known neoantigens.

About KLXE KLX Energy Services Holdings Inc.

KLX Energy Services Holdings Inc is a provider of completion, intervention and production services and products to the onshore oil and gas producing regions of the United States. It serves the companies engaged in the exploration and development of onshore conventional and unconventional oil and natural gas reserves. Its products and services offerings include surface facilities and equipment, pressure control services, wireline services, fishing services, and engineered products. The company's segments include Southwest; Rocky Mountains and Northeast/Mid-Con region. It derives maximum revenue from Northeast/Mid-Con region.

Share on Social Networks: